57 results
8-K
EX-99.1
c58x k6v9kjf3x0jl
8 Jun 22
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
zfg86 e9hv5
30 Dec 21
Immunovant Provides Regulatory Update Regarding Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022
7:05am
8-K
EX-99.2
pdo u77cz
17 Nov 21
Immunovant to Present at the Stifel 2021 Virtual Healthcare Conference
8:36am
8-K
EX-99.1
4tkvsoyteva9ts9e9yz
9 Aug 21
Company Ended the Quarter With Cash of Approximately $379 Million
6:56am
PRE 14A
4cth bfdgzipoqd2gn6
2 Aug 21
Preliminary proxy
4:31pm
8-K
EX-99.1
pwniwbckcca0qgc6k9x
1 Jun 21
Results of Operations and Financial Condition
7:36am